Stephen P. Carey

2019

In 2019, Stephen P. Carey earned a total compensation of $2.2M as Vice President, Finance and Chief Financial Officer at ANI Pharmaceuticals, a 50% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$252,120
Option Awards$610,092
Salary$456,877
Stock Awards$826,622
Other$10,681
Total$2,156,392

Carey received $826.6K in stock awards, accounting for 38% of the total pay in 2019.

Carey also received $252.1K in non-equity incentive plan, $610.1K in option awards, $456.9K in salary and $10.7K in other compensation.

Rankings

In 2019, Stephen P. Carey's compensation ranked 5,535th out of 13,971 executives tracked by ExecPay. In other words, Carey earned more than 60.4% of executives.

ClassificationRankingPercentile
All
5,535
out of 13,971
60th
Division
Manufacturing
2,070
out of 5,701
64th
Major group
Chemicals And Allied Products
737
out of 2,200
67th
Industry group
Drugs
619
out of 1,886
67th
Industry
Pharmaceutical Preparations
455
out of 1,398
68th

Pay ratio

Stephen P. Carey's Pay$2,156,392
Median Employee's Pay$46,642
Pay Ratio

46

to 1

In 2019, the annual total compensation of Stephen P. Carey was $2,156,392.

The annual total compensation of the median employee at ANI Pharmaceuticals was $46,642.

The ratio of Stephen P. Carey's pay to the pay of median employee was therefore 46 to one.

Source: SEC filing on April 23, 2020.

Carey's colleagues

We found three more compensation records of executives who worked with Stephen P. Carey at ANI Pharmaceuticals in 2019.

2019

Arthur Przybyl

ANI Pharmaceuticals

Chief Executive Officer

2019

Robert Schrepfer

ANI Pharmaceuticals

Senior Vice President, New Business Development and Specialty Sales

2019

James Marken

ANI Pharmaceuticals

Senior Vice President, Operations and Product Development

News

You may also like